Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of Nanobiotechnology|February 1, 2025
Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancerSangsang Tang, Yangyang Li, Yifeng Fang, et al.
Iscience|August 26, 2024
FXN targeting induces cell death in ovarian cancer stem-like cells through PRDX3-Mediated oxidative stressShanshan Xu, Yuwan Liu, Shizhou Yang, et al.
Journal of Gynecologic Oncology|July 7, 2026
Performance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal massesNingtao Cheng, Mengyan Tu, Chenchun Zhang, et al.
Photodiagnosis and Photodynamic Therapy|June 15, 2025
Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zoneRuizhe Chen, Junfen Xu, Chun Ye, et al.
Molecular Therapy. Nucleic Acids|December 14, 2020
circEYA1 Functions as a Sponge of miR-582-3p to Suppress Cervical Adenocarcinoma Tumorigenesis via Upregulating CXCL14Junfen Xu, Yanan Zhang, Yongjie Huang, et al.
Cell Death Discovery|September 23, 2021
Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitorsJunfen Xu, Yuanming Shen, Conghui Wang, et al.
Frontiers in Pharmacology|August 19, 2024
Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer developmentYing Luo, Mengda Niu, Yanfei Liu, et al.
Oncogene|January 12, 2019
Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiationShiyuan Hong, Junfen Xu, Yan Li, et al.
Research (Washington, D.C.)|March 17, 2023
Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian CancerYangyang Li, Yixuan Cen, Mengyan Tu, et al.
Oncotarget|May 7, 2016
CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesisJunfen Xu, Yifeng Fang, Xinyu Wang, et al.
Pageof 8